OraQuick HIV Self-Test that will increase access to HIV testing for adolescents. The change expands the approved age range to include individuals 14 years of age and older for the OraQuick HIV Self-Test. Previously the test was approved for use in those 17 and older. “Increasing access to different testing options is critical to ending the HIV epidemic for all people, and early connection to care is essential for adolescents who test positive for HIV,” said Carrie Eglinton Manner, President and CEO of OraSure (OSUR) Technologies.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on OSUR:
- OraSure price target lowered to $4 from $5 at Evercore ISI
- OraSure Technologies Acquires Sherlock Biosciences for Growth
- OraSure acquires Sherlock Biosciences, terms undisclosed
- OraSure receives federal funding for development of Marburg Virus test
The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.
